SCOPUS 정보 검색 플랫폼

Current Opinion in Drug Discovery and Development

Volumn 12, Issue 4, 2009, Pages 443-445

Personalized medicine - A paradigm for a sustainable pharmaceutical industry?

(2) Chackalamannil, Samuel a Desai, Manoj C b

a MERCK RESEARCH LABORATORIES (United States)

b GILEAD SCIENCES (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ABACAVIR; AZATHIOPRINE; BCR ABL PROTEIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLUCURONOSYLTRANSFERASE 1A1; IMATINIB; IRINOTECAN; PRAVASTATIN; TRASTUZUMAB; VITESPEN; WARFARIN;

BREAST CANCER; CANCER IMMUNIZATION; CHRONIC MYELOID LEUKEMIA; COMMERCIAL PHENOMENA; DRUG INDUSTRY; DRUG METABOLISM; DRUG TARGETING; GENETIC TRAIT; GENOMICS; HUMAN; HYPERCHOLESTEROLEMIA; MELANOMA; NEUTROPENIA; PATIENT CARE; PERSONALIZED MEDICINE; PHARMACOGENETICS; REVIEW;

DRUG DISCOVERY; DRUG INDUSTRY; INDIVIDUALIZED MEDICINE;

EID: 67649979950 PISSN: 13676733 EISSN: None Source Type: Journal
DOI: None Document Type: Review

Times cited : (4)

References (11)

1
- 40949137819
- The genome gets personal - almost
- Feero GW, Guttmacher AE, Collins FS: The genome gets personal - almost. J Am Med Assoc (2008) 299(11):1351-1352.
- (2008) J Am Med Assoc , vol.299 , Issue.11 , pp. 1351-1352
- Feero, G.W.¹ Guttmacher, A.E.² Collins, F.S.³

2
- 64249100539
- Willard HF, Ginburg GS Eds, Academic Press, San Diego, CA, USA
- Willard HF, Ginburg GS (Eds): Genomic and Personalized Medicine. Academic Press, San Diego, CA, USA (2009).
- (2009) Genomic and Personalized Medicine

3
- 65949104586
- Genomewide association studies and human disease
- Hardy J, Singleton S: Genomewide association studies and human disease. N Engl J Med (2009) 360(17):1759-1768.
- (2009) N Engl J Med , vol.360 , Issue.17 , pp. 1759-1768
- Hardy, J.¹ Singleton, S.²

4
- 0036635291
- Glivec (ST1571, imatinib), a rationally developed, targeted anticancer drug
- Capdeville R, Buchdunger E, Zimmermann J, Matter A: Glivec (ST1571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov (2000) 1(7):493-502.
- (2000) Nat Rev Drug Discov , vol.1 , Issue.7 , pp. 493-502
- Capdeville, R.¹ Buchdunger, E.² Zimmermann, J.³ Matter, A.⁴

5
- 63449090236
- Pharmacogenetics: From discovery to patient care
- Shin J, Kayser SR, Langaee TY: Pharmacogenetics: From discovery to patient care. Am J Health Syst Pharm (2009) 66(7):625-637.
- (2009) Am J Health Syst Pharm , vol.66 , Issue.7 , pp. 625-637
- Shin, J.¹ Kayser, S.R.² Langaee, T.Y.³

6
- 84884753193
- The role of genomics and genetics in drug discovery and development
- Willard HF, Ginburg GS Eds, Academic Press, San Diego, CA, USA
- Tepper RI, Roubenoff R: The role of genomics and genetics in drug discovery and development. In: Genomic and Personalized Medicine. Willard HF, Ginburg GS (Eds), Academic Press, San Diego, CA, USA (2009):335-356.
- (2009) Genomic and Personalized Medicine , pp. 335-356
- Tepper, R.I.¹ Roubenoff, R.²

7
- 57649220640
- Oncophage: Step to the future for vaccine therapy in melanoma
- di Pietro A, Tosti G, Ferrucci PF, Testori A: Oncophage: Step to the future for vaccine therapy in melanoma. Expert Opin Biol Ther(2008) 8(12):1973-1984.
- (2008) Expert Opin Biol Ther , vol.8 , Issue.12 , pp. 1973-1984
- di Pietro, A.¹ Tosti, G.² Ferrucci, P.F.³ Testori, A.⁴

8
- 26844457534
- The distinctive nature of HER2-positive breast cancer
- Burstein HJ: The distinctive nature of HER2-positive breast cancer. N Engl J Med (2005) 353(16):1652-1654.
- (2005) N Engl J Med , vol.353 , Issue.16 , pp. 1652-1654
- Burstein, H.J.¹

9
- 64049096916
- The microeconomics of personalized medicine: Today's challenges and tomorrow's promise
- Davis JC, Furstenthal L, Desai AA, Norris T, Sutaria S, Fleming E, Ma P: The microeconomics of personalized medicine: Today's challenges and tomorrow's promise. Nat Rev Drug Discov (2009) 8(4):279-286.
- (2009) Nat Rev Drug Discov , vol.8 , Issue.4 , pp. 279-286
- Davis, J.C.¹ Furstenthal, L.² Desai, A.A.³ Norris, T.⁴ Sutaria, S.⁵ Fleming, E.⁶ Ma, P.⁷

10
- 2942627194
- Pharmacogenetic study of statin therapy and cholesterol reduction
- Chasman DI, Posada D, Subrahmanyan L, Cook NR, Stanton VP Jr, Ridker PM: Pharmacogenetic study of statin therapy and cholesterol reduction. J Am Med Assoc (2004) 291(23):2821- 2827.
- (2004) J Am Med Assoc , vol.291 , Issue.23 , pp. 2821-2827
- Chasman, D.I.¹ Posada, D.² Subrahmanyan, L.³ Cook, N.R.⁴ Stanton Jr, V.P.⁵ Ridker, P.M.⁶

11
- 33947712686
- Herceptin historical sales: Genentech, San Francisco, CA, USA (2009). www.gene.com/gene/ir/financials/historical/herceptin.html12. Novartis annual report 2008: Novartis, Basel, Switzerland (2009). www.novartis.com/investors/sales-results/index.shtml13. Trusheim MR, Berndt ER, Douglas FL: Stratified medicine: Strategic and economic implications of combining drugs and clinical biomarkers. Nat Rev Drug Discov (2007) 6(4):287-293.
- Herceptin historical sales: Genentech, San Francisco, CA, USA (2009). www.gene.com/gene/ir/financials/historical/herceptin.html12. Novartis annual report 2008: Novartis, Basel, Switzerland (2009). www.novartis.com/investors/sales-results/index.shtml13. Trusheim MR, Berndt ER, Douglas FL: Stratified medicine: Strategic and economic implications of combining drugs and clinical biomarkers. Nat Rev Drug Discov (2007) 6(4):287-293.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.